FDA Approved Products

1,302 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
Active:Lifecycle: PeakClear all
HELIUM, USP
helium
Peak
INHALATION · GAS
2018
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2016
NDA
30/100
HELIUM, USP
helium, oxygen
Peak
INHALATION · GAS
2013
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2021
NDA
30/100
HELIUM, USP
helium
Peak
Advanced Solutions Life Sciences
INHALATION · GAS
2013
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2019
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2013
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2013
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2020
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2019
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2013
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2019
NDA
30/100
HEPARIN SODIUM
heparin sodium
Peak
Pfizer
INJECTION · INJECTABLE
acutechronic consumption coagulopathies (disseminated intravascular coagulation)+3
2011
NDA
30/100
HEPARIN SODIUM PRESERVATIVE FREE
heparin sodium
Peak
Pfizer
INJECTION · INJECTABLE
acutechronic consumption coagulopathies (disseminated intravascular coagulation)+3
2011
NDA
30/100
HYCOFENIX
guaifenesin; hydrocodone bitartrate; pseudoephedrine hydrochloride
Peak
Molecular Devices
ORAL · SOLUTION
2015
NDA
30/100
HYDROMORPHONE HYDROCHLORIDE
hydromorphone hydrochloride
Peak
Pfizer
INJECTION · INJECTABLE
pain severe enough to require an opioid analgesicfor which alternative treatments are inadequate
2011
NDA
30/100
HYFTOR
sirolimus
Peak
TOPICAL · GEL
2022
NDA
30/100
IMPAVIDO
miltefosine
Peak
Knight Therapeutics
ORAL · CAPSULE
adolescents ≥12 years of age weighing ≥30 kg (66 lbs) for treatment of: Visceral leishmaniasis due to Leishmania donovani ( )
2014
NDA
30/100
IMPEKLO
clobetasol propionate
Peak
TOPICAL · LOTION
2020
NDA
30/100
IRESSA
gefitinib
Peak
AstraZeneca
ORAL · TABLET
2015
SMNDA
30/100
ISOPTO ATROPINE
atropine sulfate
Peak
Alcon
OPHTHALMIC · SOLUTION/DROPS
2016
NDA
30/100
JADENU SPRINKLE
deferasirox
Peak
Novartis
ORAL · GRANULE
2017
NDA
30/100
KERYDIN
tavaborole
Peak
R-Pharm US
TOPICAL · SOLUTION
2014
NDA
30/100
KHEDEZLA
desvenlafaxine
Peak
ORAL · TABLET, EXTENDED RELEASE
2013
NDA
30/100
← PreviousPage 7 of 55Next →